Published in J Biol Chem on December 07, 2009
Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo. J Invest Dermatol (2015) 1.51
Trypsin-induced proteome alteration during cell subculture in mammalian cells. J Biomed Sci (2010) 1.29
Repetitive peroxide exposure reveals pleiotropic mitogen-activated protein kinase signaling mechanisms. J Signal Transduct (2010) 0.86
Activation of the EGFR/p38/JNK pathway by mitochondrial-derived hydrogen peroxide contributes to oxygen-induced contraction of ductus arteriosus. J Mol Med (Berl) (2014) 0.83
Expression levels of some antioxidant and epidermal growth factor receptor genes in patients with early-stage non-small cell lung cancer. J Nucleic Acids (2010) 0.80
Dioscorin pre-treatment protects A549 human airway epithelial cells from hydrogen peroxide-induced oxidative stress. Inflammation (2013) 0.78
Molecular dynamics simulations of transitions for ECD epidermal growth factor receptors show key differences between human and drosophila forms of the receptors. Proteins (2013) 0.78
Role for Tyrosine Phosphorylation of A-kinase Anchoring Protein 8 (AKAP8) in Its Dissociation from Chromatin and the Nuclear Matrix. J Biol Chem (2015) 0.77
Aquaporin 3 and E-Cadherin Expression in Perilesional Vitiligo Skin. J Clin Diagn Res (2016) 0.75
Modulation of cutaneous extracellular collagen contraction by phosphorylation status of p130Cas. J Physiol Sci (2016) 0.75
Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer (2002) 20.51
Oncogenic kinase signalling. Nature (2001) 16.30
Assembly of cell regulatory systems through protein interaction domains. Science (2003) 10.59
Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science (1995) 8.17
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol (2004) 7.69
Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem (1997) 4.51
Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem (1998) 4.05
Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry (1998) 3.90
Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol (2005) 3.83
Regulation of E-cadherin/Catenin association by tyrosine phosphorylation. J Biol Chem (1999) 3.53
Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc Natl Acad Sci U S A (2004) 3.49
Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE (2000) 3.45
Structure and regulation of Src family kinases. Oncogene (2004) 3.44
Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc Natl Acad Sci U S A (1999) 3.43
The interplay between Src family kinases and receptor tyrosine kinases. Oncogene (2004) 3.36
v-Src's hold over actin and cell adhesions. Nat Rev Mol Cell Biol (2002) 2.40
Redox-dependent signal transduction. FEBS Lett (2000) 2.14
Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res (2005) 1.95
Sequential activation of phosphatidylinositol 3-kinase, beta Pix, Rac1, and Nox1 in growth factor-induced production of H2O2. Mol Cell Biol (2004) 1.82
Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J Cell Sci (2002) 1.72
c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1. J Biol Chem (1997) 1.71
Platelet-derived growth factor-induced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem (2000) 1.62
Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol Cell Proteomics (2002) 1.60
The actin cytoskeleton response to oxidants: from small heat shock protein phosphorylation to changes in the redox state of actin itself. Free Radic Biol Med (2001) 1.60
SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J Biol Chem (2000) 1.56
Expression of kinase-inactive c-Src delays oxidative stress-induced disassembly and accelerates calcium-mediated reassembly of tight junctions in the Caco-2 cell monolayer. J Biol Chem (2003) 1.56
c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation. J Biol Chem (2001) 1.49
Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism. J Cell Sci (2008) 1.48
Galpha12 regulates protein interactions within the MDCK cell tight junction and inhibits tight-junction assembly. J Cell Sci (2008) 1.41
Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells. Cancer Res (2002) 1.33
EGFR signaling to p120-catenin through phosphorylation at Y228. J Cell Sci (2004) 1.25
Tyrosine phosphorylated Par3 regulates epithelial tight junction assembly promoted by EGFR signaling. EMBO J (2006) 1.22
Analysis of proviral integration in human mammary epithelial cell lines immortalized by retroviral infection with a temperature-sensitive SV40 T-antigen construct. Int J Cancer (1994) 1.21
Differential redox regulation within the PTP superfamily. Cell Signal (2007) 1.15
Proteomic analysis of redox- and ErbB2-dependent changes in mammary luminal epithelial cells using cysteine- and lysine-labelling two-dimensional difference gel electrophoresis. Proteomics (2005) 1.14
ROS up-regulation mediates Ras-induced changes of cell morphology and motility. Exp Cell Res (2006) 1.11
H2O2-induced transactivation of EGF receptor requires Src and mediates ERK1/2, but not Akt, activation in renal cells. Am J Physiol Renal Physiol (2004) 1.07
Effects of ErbB-2 overexpression on mitogenic signalling and cell cycle progression in human breast luminal epithelial cells. Oncogene (2002) 1.07
The fate of desmosomal proteins in apoptotic cells. J Biol Chem (2001) 1.04
The growth of research on protein phosphorylation. Trends Biochem Sci (1994) 1.02
Evidence of a novel redox-linked activation mechanism for the Src kinase which is independent of tyrosine 527-mediated regulation. Oncogene (1996) 1.00
Reactive oxygen species activate focal adhesion kinase, paxillin and p130cas tyrosine phosphorylation in endothelial cells. Free Radic Biol Med (1998) 0.99
H2O2-induced phosphorylation of ERK1/2 and PKB requires tyrosine kinase activity of insulin receptor and c-Src. Antioxid Redox Signal (2005) 0.97
Actin re-distribution in response to hydrogen peroxide in airway epithelial cells. J Cell Physiol (2004) 0.95
Effects of H2O2 on protein tyrosine phosphatase activity in HER14 cells. Free Radic Biol Med (1994) 0.90
Oxidant-induced priming of the macrophage involves activation of p38 mitogen-activated protein kinase through an Src-dependent pathway. Surgery (2003) 0.88
Independent regulation of adherens and tight junctions by tyrosine phosphorylation in Caco-2 cells. Biochim Biophys Acta (1999) 0.87
Cellular responses to ErbB-2 overexpression in human mammary luminal epithelial cells: comparison of mRNA and protein expression. Br J Cancer (2004) 0.84
Free radicals are involved in continuous activation of nonreceptor tyrosine protein kinase c-Src after ischemia/reperfusion in rat hippocampus. Neurosci Lett (2003) 0.83
Redox regulation of phosphatase function. Biochem Soc Trans (2004) 0.82
Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science (2002) 6.01
Exploring the specificity of the PI3K family inhibitor LY294002. Biochem J (2007) 2.66
A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral budding. EMBO Rep (2008) 2.09
Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol Cell Proteomics (2002) 1.60
Genomic characterization of Campylobacter jejuni strain M1. PLoS One (2010) 1.44
Synthesis and biological evaluation of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110alpha inhibitors. Bioorg Med Chem Lett (2007) 1.33
Wiskott-Aldrich syndrome protein and the cytoskeletal dynamics of dendritic cells. J Pathol (2004) 1.31
Trypsin-induced proteome alteration during cell subculture in mammalian cells. J Biomed Sci (2010) 1.29
AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D. Cancer Res (2011) 1.26
Cluster analysis of an extensive human breast cancer cell line protein expression map database. Proteomics (2002) 1.22
Role of WASP in cell polarity and podosome dynamics of myeloid cells. Eur J Cell Biol (2010) 1.20
Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110alpha inhibitors. Bioorg Med Chem (2006) 1.15
Proteomic analysis of redox- and ErbB2-dependent changes in mammary luminal epithelial cells using cysteine- and lysine-labelling two-dimensional difference gel electrophoresis. Proteomics (2005) 1.14
Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2-a]pyridines as novel PI3 kinase p110alpha inhibitors. Bioorg Med Chem (2007) 1.10
Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis. J Proteome Res (2010) 1.09
The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res (2007) 1.09
Cytolethal distending toxin (CDT)-negative Campylobacter jejuni strains and anti-CDT neutralizing antibodies are induced during human infection but not during colonization in chickens. Infect Immun (2005) 1.08
Phosphoinositide 3-Kinase C2beta regulates cytoskeletal organization and cell migration via Rac-dependent mechanisms. Mol Biol Cell (2006) 1.07
Effects of ErbB-2 overexpression on mitogenic signalling and cell cycle progression in human breast luminal epithelial cells. Oncogene (2002) 1.07
Lectin microarray profiling of metastatic breast cancers. Glycobiology (2011) 1.06
Dynamic cofilin phosphorylation in the control of lamellipodial actin homeostasis. J Cell Sci (2007) 1.06
Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation. EMBO J (2002) 1.06
Structural and membrane binding analysis of the Phox homology domain of phosphoinositide 3-kinase-C2alpha. J Biol Chem (2006) 1.05
The cytoplasmic tail of L-selectin interacts with members of the Ezrin-Radixin-Moesin (ERM) family of proteins: cell activation-dependent binding of Moesin but not Ezrin. J Biol Chem (2001) 1.05
RhoE Is required for keratinocyte differentiation and stratification. Mol Biol Cell (2008) 1.05
Heat shock protein 27 is the major differentially phosphorylated protein involved in renal epithelial cellular stress response and controls focal adhesion organization and apoptosis. J Biol Chem (2005) 1.04
A parallel proteomic and metabolomic analysis of the hydrogen peroxide- and Sty1p-dependent stress response in Schizosaccharomyces pombe. Proteomics (2006) 1.04
Analysis of the urine proteome in patients with pancreatic ductal adenocarcinoma. Proteomics Clin Appl (2008) 1.03
Proteomics study of oxidative stress and Src kinase inhibition in H9C2 cardiomyocytes: a cell model of heart ischemia-reperfusion injury and treatment. Free Radic Biol Med (2010) 0.99
Negative feedback regulation of Rac in leukocytes from mice expressing a constitutively active phosphatidylinositol 3-kinase gamma. Proc Natl Acad Sci U S A (2007) 0.98
Proteomic profiling of neuromas reveals alterations in protein composition and local protein synthesis in hyper-excitable nerves. Mol Pain (2008) 0.98
Cryptic ecology among host generalist Campylobacter jejuni in domestic animals. Mol Ecol (2014) 0.97
Quantitative profiling of serum samples using TMT protein labelling, fractionation and LC-MS/MS. Methods (2011) 0.97
Gene targeting: attention to detail. Cell (2004) 0.95
Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers. Funct Integr Genomics (2011) 0.94
Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration. Blood (2002) 0.93
A targeted glycoproteomic approach identifies cadherin-5 as a novel biomarker of metastatic breast cancer. Cancer Lett (2012) 0.92
Proteomic analysis of UVC irradiation-induced damage of plasma proteins: Serum amyloid P component as a major target of photolysis. FEBS Lett (2006) 0.92
Differential proteome analysis of replicative senescence in rat embryo fibroblasts. Mol Cell Proteomics (2002) 0.91
Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells. Mol Biosyst (2011) 0.89
Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours. Anticancer Res (2012) 0.89
Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells--interplay of ErbB and IGF1 signalling through IGFBP3 regulation. BMC Cancer (2010) 0.88
Effect of high glucose on secreted proteome in cultured retinal pigmented epithelium cells: its possible relevance to clinical diabetic retinopathy. J Proteomics (2012) 0.88
Proteomic response of Schizosaccharomyces pombe to static and oscillating extremely low-frequency electromagnetic fields. Proteomics (2006) 0.88
Proteomics-based identification of plasma biomarkers in oral squamous cell carcinoma. J Pharm Biomed Anal (2012) 0.87
A well-characterised peak identification list of MALDI MS profile peaks for human blood serum. Proteomics (2010) 0.87
Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity. Cancer Res (2011) 0.87
Cardioprotective Effects of Quercetin in Cardiomyocyte under Ischemia/Reperfusion Injury. Evid Based Complement Alternat Med (2013) 0.86
Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging. J Proteomics (2011) 0.86
Proteomic analysis of UVB-induced protein expression- and redox-dependent changes in skin fibroblasts using lysine- and cysteine-labeling two-dimensional difference gel electrophoresis. J Proteomics (2012) 0.86
Characterization of protein phosphorylation by mass spectrometry using immobilized metal ion affinity chromatography with on-resin beta-elimination and Michael addition. Anal Chem (2003) 0.85
Identification of novel candidates for replicative senescence by functional proteomics. Oncogene (2002) 0.85
Hyaluronic acid-dependent protection in H9C2 cardiomyocytes: a cell model of heart ischemia-reperfusion injury and treatment. Toxicology (2012) 0.85
Targeted expression of the class II phosphoinositide 3-kinase in Drosophila melanogaster reveals lipid kinase-dependent effects on patterning and interactions with receptor signaling pathways. Mol Cell Biol (2004) 0.84
Evidence for phenotypic plasticity among multihost Campylobacter jejuni and C. coli lineages, obtained using ribosomal multilocus sequence typing and Raman spectroscopy. Appl Environ Microbiol (2012) 0.84
Proteomic and redox-proteomic analysis of berberine-induced cytotoxicity in breast cancer cells. J Proteomics (2012) 0.84
Hyaluronic acid-dependent protection against UVB-damaged human corneal cells. Environ Mol Mutagen (2013) 0.82
Structural analysis of PI3-kinase isoforms: identification of residues enabling selective inhibition by small molecule ATP-competitive inhibitors. Arch Biochem Biophys (2008) 0.82
Proteomic identification of plasma biomarkers in uterine leiomyoma. Mol Biosyst (2011) 0.82
Hyaluronic acid-dependent protection against alkali-burned human corneal cells. Electrophoresis (2013) 0.81
Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancer. J Cell Mol Med (2015) 0.81
Plasma proteomic analysis of the critical limb ischemia markers in diabetic patients with hemodialysis. Mol Biosyst (2011) 0.81
Characterisation of tumoral markers correlated with ErbB2 (HER2/Neu) overexpression and metastasis in breast cancer. Proteomics Clin Appl (2008) 0.80
High glucose-induced proteome alterations in hepatocytes and its possible relevance to diabetic liver disease. J Nutr Biochem (2013) 0.80
Proteomic analysis of proteins responsible for the development of doxorubicin resistance in human uterine cancer cells. J Proteomics (2012) 0.80
Hemopexin is up-regulated in plasma from type 1 diabetes mellitus patients: Role of glucose-induced ROS. J Proteomics (2012) 0.80
Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling. Int J Gynecol Cancer (2010) 0.79
Approaches and applications of quantitative LC-MS for proteomics and activitomics. Methods Mol Biol (2010) 0.79
Stress-induced changes in the Schizosaccharomyces pombe proteome using two-dimensional difference gel electrophoresis, mass spectrometry and a novel integrated robotics platform. Proteomics (2005) 0.78
IMAC/TiO(2) enrich for peptide modifications other than phosphorylation: implications for chromatographic choice and database searching in phosphoproteomics. Proteomics (2011) 0.78
A biotinylated analog of the anti-proliferative prostaglandin A1 allows assessment of PPAR-independent effects and identification of novel cellular targets for covalent modification. Chem Biol Interact (2010) 0.78
Molecular characterisation of post-bio-electrosprayed human brain astrocytoma cells. Analyst (2010) 0.78
Protein technologies. Curr Opin Biotechnol (2008) 0.78
Employing TMT quantification in a shotgun-MS platform. Methods Mol Biol (2014) 0.78
Redox-proteomic analysis of doxorubicin-induced altered thiol activity in cardiomyocytes. Mol Biosyst (2013) 0.78
Cell structure and dynamics. Curr Opin Cell Biol (2010) 0.78
Novel diagnostic and prognostic biomarkers in biliary tract cancer. Expert Opin Med Diagn (2013) 0.77
Proteome differences between male and female fetal cells in amniotic fluid. OMICS (2012) 0.77
Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells. Breast Cancer Res Treat (2014) 0.77
Proteomic analysis of redox-dependent changes using cysteine-labeling 2D DIGE. Methods Mol Biol (2012) 0.77
Proteomic and redox-proteomic study on the role of glutathione reductase in human lung cancer cells. Electrophoresis (2013) 0.76
Proteomic analysis of retinopathy-related plasma biomarkers in diabetic patients. Arch Biochem Biophys (2012) 0.76
Redox- and expression-proteomic analysis of plasma biomarkers in bladder transitional cell carcinoma. Mol Biosyst (2012) 0.76
Retraction: MMP-13 is involved in oral cancer cell metastasis. Oncotarget (2016) 0.76
Effect of glutathione reductase knockdown in response to UVB-induced oxidative stress in human lung adenocarcinoma. Proteome Sci (2014) 0.76
Nuclear proteomics with XRCC3 knockdown to reveal the development of doxorubicin-resistant uterine cancer. Toxicol Sci (2014) 0.76
Placenta proteome analysis from Down syndrome pregnancies for biomarker discovery. Mol Biosyst (2012) 0.76
Regulation and functional insights in cellular polarity, Madrid, Spain June 3-5, 2002. J Cell Biol (2002) 0.75
Functional proteomic analysis of long-term growth factor stimulation and receptor tyrosine kinase coactivation in Swiss 3T3 fibroblasts. Mol Cell Proteomics (2012) 0.75
Proteomic profiling of ovarian cancer models using TMT-LC-MS/MS. Methods Mol Biol (2013) 0.75
Proteomic analysis of prognostic plasma biomarkers in peripheral arterial occlusive disease. Mol Biosyst (2017) 0.75